145 related articles for article (PubMed ID: 29024407)
1. Ghrelin deletion protects against age-associated hepatic steatosis by downregulating the C/EBPα-p300/DGAT1 pathway.
Guillory B; Jawanmardi N; Iakova P; Anderson B; Zang P; Timchenko NA; Garcia JM
Aging Cell; 2018 Feb; 17(1):. PubMed ID: 29024407
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of enzymes of triglyceride synthesis is essential for the development of hepatic steatosis.
Jin J; Iakova P; Breaux M; Sullivan E; Jawanmardi N; Chen D; Jiang Y; Medrano EM; Timchenko NA
Cell Rep; 2013 Mar; 3(3):831-43. PubMed ID: 23499441
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
4. Dietary Macronutrient Composition Determines the Contribution of DGAT1 to Alcoholic Steatosis.
Huang LS; Yuen JJ; Trites MJ; Saha A; Epps CT; Hu Y; Kerolle S; Lee SA; Jiang H; Goldberg IJ; Blaner WS; Clugston RD
Alcohol Clin Exp Res; 2018 Dec; 42(12):2298-2312. PubMed ID: 30192394
[TBL] [Abstract][Full Text] [Related]
5. Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids.
Villanueva CJ; Monetti M; Shih M; Zhou P; Watkins SM; Bhanot S; Farese RV
Hepatology; 2009 Aug; 50(2):434-42. PubMed ID: 19472314
[TBL] [Abstract][Full Text] [Related]
6. Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice.
Lee B; Fast AM; Zhu J; Cheng JX; Buhman KK
J Lipid Res; 2010 Jul; 51(7):1770-80. PubMed ID: 20147738
[TBL] [Abstract][Full Text] [Related]
7. Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2008 Feb; 47(2):625-35. PubMed ID: 18000880
[TBL] [Abstract][Full Text] [Related]
8. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice.
Gluchowski NL; Gabriel KR; Chitraju C; Bronson RT; Mejhert N; Boland S; Wang K; Lai ZW; Farese RV; Walther TC
Hepatology; 2019 Dec; 70(6):1972-1985. PubMed ID: 31081165
[TBL] [Abstract][Full Text] [Related]
10. DS-7250, a Diacylglycerol Acyltransferase 1 Inhibitor, Enhances Hepatic Steatosis in Zucker Fatty Rats via Upregulation of Fatty Acid Synthesis.
Yasuno K; Kumagai K; Iguchi T; Tsuchiya Y; Kai K; Mori K
Toxicol Pathol; 2018 Apr; 46(3):302-311. PubMed ID: 29587622
[TBL] [Abstract][Full Text] [Related]
11. Activation of CDK4 Triggers Development of Non-alcoholic Fatty Liver Disease.
Jin J; Valanejad L; Nguyen TP; Lewis K; Wright M; Cast A; Stock L; Timchenko L; Timchenko NA
Cell Rep; 2016 Jul; 16(3):744-56. PubMed ID: 27373160
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Diacylglycerol Acyltransferase 2 Versus Diacylglycerol Acyltransferase 1: Potential Therapeutic Implications of Pharmacology.
Amin NB; Saxena AR; Somayaji V; Dullea R
Clin Ther; 2023 Jan; 45(1):55-70. PubMed ID: 36690550
[TBL] [Abstract][Full Text] [Related]
13. Loss of 5α-reductase type 1 accelerates the development of hepatic steatosis but protects against hepatocellular carcinoma in male mice.
Dowman JK; Hopkins LJ; Reynolds GM; Armstrong MJ; Nasiri M; Nikolaou N; van Houten EL; Visser JA; Morgan SA; Lavery GG; Oprescu A; Hübscher SG; Newsome PN; Tomlinson JW
Endocrinology; 2013 Dec; 154(12):4536-47. PubMed ID: 24080367
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.
Monetti M; Levin MC; Watt MJ; Sajan MP; Marmor S; Hubbard BK; Stevens RD; Bain JR; Newgard CB; Farese RV; Hevener AL; Farese RV
Cell Metab; 2007 Jul; 6(1):69-78. PubMed ID: 17618857
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.
Alonso C; Fernández-Ramos D; Varela-Rey M; Martínez-Arranz I; Navasa N; Van Liempd SM; Lavín Trueba JL; Mayo R; Ilisso CP; de Juan VG; Iruarrizaga-Lejarreta M; delaCruz-Villar L; Mincholé I; Robinson A; Crespo J; Martín-Duce A; Romero-Gómez M; Sann H; Platon J; Van Eyk J; Aspichueta P; Noureddin M; Falcón-Pérez JM; Anguita J; Aransay AM; Martínez-Chantar ML; Lu SC; Mato JM
Gastroenterology; 2017 May; 152(6):1449-1461.e7. PubMed ID: 28132890
[TBL] [Abstract][Full Text] [Related]
16. Elimination of Age-Associated Hepatic Steatosis and Correction of Aging Phenotype by Inhibition of cdk4-C/EBPα-p300 Axis.
Nguyen P; Valanejad L; Cast A; Wright M; Garcia JM; El-Serag HB; Karns R; Timchenko NA
Cell Rep; 2018 Aug; 24(6):1597-1609. PubMed ID: 30089269
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
[TBL] [Abstract][Full Text] [Related]
18. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
19. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.
Rahman SM; Schroeder-Gloeckler JM; Janssen RC; Jiang H; Qadri I; Maclean KN; Friedman JE
Hepatology; 2007 May; 45(5):1108-17. PubMed ID: 17464987
[TBL] [Abstract][Full Text] [Related]
20. Genetic Ablation of C/EBPα-p300 Pathway Blocks Development of Obese Pregnancy Associated Liver Disorders in Offspring.
Hanlon MA; Gulati R; Johnston M; Fleifil Y; Rivas M; Timchenko NA
Cell Mol Gastroenterol Hepatol; 2024; 17(3):347-360. PubMed ID: 37967813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
